The effects of alpha-lipoic acid supplementation on muscle atrophy after anterior cruciate ligament reconstruction.
Not Applicable
Completed
- Conditions
- anterior cruciate ligament reconstruction
- Registration Number
- JPRN-jRCT1091220219
- Lead Sponsor
- Daisuke Ando
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
The patients diagnosed as anterior cruciate ligament injury.
Exclusion Criteria
Subjects were excluded if they were currently using antioxidant supplements.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method muscle volume
- Secondary Outcome Measures
Name Time Method oxidative stress markers, inflammation markers
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link alpha-lipoic acid to muscle atrophy prevention post-ACL reconstruction?
How does alpha-lipoic acid supplementation compare to standard-of-care treatments for post-ACL muscle atrophy?
Are there specific biomarkers that predict response to alpha-lipoic acid in ACL reconstruction recovery?
What adverse events are associated with alpha-lipoic acid use after anterior cruciate ligament surgery?
What combination therapies with antioxidants show promise in preventing muscle atrophy post-ACL injury?